Page last updated: 2024-11-04

terbutaline and Child Development Disorders, Pervasive

terbutaline has been researched along with Child Development Disorders, Pervasive in 2 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Child Development Disorders, Pervasive: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caritis, SN1
Simhan, HN1
Rodier, P1
Miller, RK1
Brent, RL1

Other Studies

2 other studies available for terbutaline and Child Development Disorders, Pervasive

ArticleYear
Beta adrenergic agonists and neonatal outcome.
    American journal of obstetrics and gynecology, 2010, Volume: 203, Issue:4

    Topics: Adrenergic Agonists; Animals; Child; Child Development Disorders, Pervasive; Female; Humans; Pregnan

2010
Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders?
    American journal of obstetrics and gynecology, 2011, Volume: 204, Issue:2

    Topics: Child Development Disorders, Pervasive; Female; Humans; Infant, Newborn; Obstetric Labor, Premature;

2011